Dr. Amit Kumar

Introduction

Expertise

• Dr. Amit Kumar is Consultant, Paediatric Oncology at HCG
• He pursued Fellowship in Paediatric Oncology from prestigious Tata Memorial Centre, Mumbai. Before joining HCG, he was associated with B J Wadia Hospital for Children as Consultant in Paediatric Haematology and Oncology.
• With over 12 years of experience in Paediatrics and Paediatric Haematology and Oncology, his areas of interest includes all kind of haematological cancers (like leukaemia's, Lymphomas, LCH etc.) and solid tumors like Ewing's Sarcoma, Osteosarcoma, Rhabdomyosarcoma, Hepatoblastoma,Wilm’s Tumour, Neuroblastoma Etc.
• He has handful of publications and Presentations at different platforms.
• His Presentation on AML was judged as best paper in Poster category SIOP ASIA conference in March 2021.

Training and Certifications

• He has completed his fellowship training in paediatric oncology from Tata Memorial Hospital, Mumbai.

Recognition

• He was awarded as Best paper presentation in Poster category in SIOP ASIA conference in March 2021 for his presentation on Effectiveness of oral metronomic chemotherapy as a bridge to high dose chemotherapy in AML presenting with fungal pneumonia AND /OR MDR BUG in rectal swab.
• He is a member of various Professional bodies in India like IAP, PHO-IAP, AMC,NNF and others
• He has been a DNB teacher for Post Graduate Students in Pediatrics and has been a DNB Thesis Guide

Publications

• Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1): An Experience from a Tertiary Care Center in North India (Indian J Pediatr (2010) 77:981–985)
• Effectiveness of oral metronomic chemotherapy as a bridge to high dose chemotherapy in AML presenting with fungal pneumonia AND /OR MDR BUG in rectal swab; October 2020; Pediatric Hematology Oncology Journal 5(4)DOI: 10.1016/j.phoj.2021.04.094
• Teleconsultation in pediatric hematology-oncology practice – Dawning of a new era December 2021 Pediatric Hematology Oncology Journal 6(4):S65DOI: 10.1016/j.phoj.2022.03.170
• Ghosal hematodiaphyseal dysplasia- Rare cause of refractory anemia;December 2021; Pediatric Hematology Oncology Journal 6(4):S41DOI: 10.1016/j.phoj.2022.03.103
• Transcranial doppler screening in patients with sickle cell anemia in tertiary care hospital; December 2021;Pediatric Hematology Oncology Journal 6(4):S45-S46DOI: 10.1016/j.phoj.2022.03.114
• Baseline nutrition in pediatric cancer therapy: A potential game changer December 2021 Pediatric Hematology Oncology Journal 6(4):S57DOI: 10.1016/j.phoj.2022.03.145
• Blood stream infections in pediatric oncology patients in a tertiary care setup; December 2021;Pediatric Hematology Oncology Journal 6(4):S57DOI: 10.1016/j.phoj.2022.03.146
• Clinico-hematological profile of pediatric acute megakaryoblastic leukemia - Single center experience; December 2021;Pediatric Hematology Oncology Journal 6(4):S30-S31DOI: 10.1016/j.phoj.2022.03.077

Other Doctors